LMR Partners’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-83,395
| Closed | -$125K | – | 895 |
|
|
2023
Q1 | $125K | Buy |
+83,395
| New | +$125K | ﹤0.01% | 897 |
|
|
2022
Q4 | – | Sell |
-44,733
| Closed | -$51K | – | 1185 |
|
|
2022
Q3 | $51K | Hold |
44,733
| – | – | ﹤0.01% | 1083 |
|
|
2022
Q2 | $71K | Buy |
+44,733
| New | +$71K | ﹤0.01% | 1119 |
|
|
2021
Q2 | – | Sell |
-72,194
| Closed | -$170K | – | 1229 |
|
|
2021
Q1 | $170K | Buy |
+72,194
| New | +$170K | ﹤0.01% | 809 |
|
|
2020
Q4 | – | Sell |
-40,083
| Closed | -$38K | – | 561 |
|
|
2020
Q3 | $38K | Sell |
40,083
-7,074
| -15% | -$6.71K | ﹤0.01% | 399 |
|
|
2020
Q2 | $41K | Buy |
+47,157
| New | +$41K | ﹤0.01% | 536 |
|
|
2015
Q2 | – | Sell |
-22,658
| Closed | -$91K | – | 576 |
|
|
2015
Q1 | $91K | Buy |
+22,658
| New | +$91K | 0.01% | 375 |
|